Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults.
Tiansheng WangJin-Liern HongEmily W GowerVirginia PateSeema GargJohn B BuseTil StürmerPublished in: Diabetes care (2018)
Our population-based cohort study of older U.S. adults with diabetes suggests that IBTs used for approximately 1 year do not increase the DR risk.